Right now, COVID-19 therapies are administered through infusion in a clinical setting. That's why Merck's pill could be a 'very big deal,' one expert said.
Merck and Ridgeback Therapeutics Inc.’s promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take a pill at home that can keep them from getting severely sick.
It also appeared to work against the gamma, delta, and mu variants in the roughly 40% of participants for whom sequencing was available. iframe.twitter-tweet { width: 100% !important; } The U.S. has already ordered 1.7 million treatment courses of molnupiravir at a price of about $705 for each five-day course of treatment.
These include the monoclonal antibodies developed by Eli Lilly & Co. LLY, -0.63%, Regeneron Pharmaceuticals Inc. REGN, -5.68%, and Vir Biotechnology Inc. VIR, -21.07% and GlaxoSmithKline GSK, -0.21%. Other therapies, like Gilead Sciences Inc.’s GILD, -1.85% Veklury and the steroid dexamethasone, which has been repurposed as a COVID-19 drug, are reserved for critically ill hospitalized patients
If and when authorization or approval of molnupiravir and other investigational antivirals takes place, it will likely shift the course of the pandemic and bring us one step closer to making the virus something we can live with and less of something to be feared.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sectorPositive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
Read more »
Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by halfDrugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus.
Read more »
Covid-19 Co-Parenting Update: How Does A Vaccinated Parent Co-Parent With An Anti-Vaxer?The health, safety and well-being of the child is a parent’s primary responsibility.
Read more »
Harvard Business School Suspends Most In-Person M.B.A. Classes, Networking After Covid-19 OutbreakDespite a high vaccination rate, the graduate school said dozens of breakthrough Covid-19 infections required a temporary return to remote learning.
Read more »
Here Are the Side Effects to Expect After Your COVID-19 Booster ShotAccording to a new CDC study.
Read more »
Military suicide deaths increase but not seen as linked to COVID-19 pandemicThe Pentagon's annual report on suicides among military service members shows that while the number of deaths by suicide increased slightly from 2019 to 2020, there was no indication that the pandemic led to more deaths by suicide among service members.
Read more »